carbamazepine ER capsule
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 9
Of
9
Go to page
1
July 26, 2025
Alembic Pharma gets USFDA nod for Carbamazepine Extended-Release Tablets
(Business Upturn)
- "Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Carbamazepine Extended-Release Tablets USP in strengths of 100 mg, 200 mg, and 400 mg...Carbamazepine Extended-Release Tablets are primarily used to treat seizure disorders and are also prescribed for trigeminal neuralgia, a chronic pain condition affecting the facial nerves."
ANDA • CNS Disorders
July 29, 2024
Drugs for epilepsy.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Review • CNS Disorders • Epilepsy
July 29, 2024
Comparison Table: Some oral antiseizure medications.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Clinical • Journal • CNS Disorders • Epilepsy
April 05, 2024
Drugs for bipolar disorder.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Bipolar Disorder • CNS Disorders • Depression • Mood Disorders • Psychiatry
February 16, 2024
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
(clinicaltrials.gov)
- P=N/A | N=1037352 | Terminated | Sponsor: University of New Mexico | Completed ➔ Terminated; Per PI, this study is not a clinical trial and was inadvertently entered in the system
HEOR • Trial termination • Bipolar Disorder • CNS Disorders • Mood Disorders • Psychiatry
March 01, 2023
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
(clinicaltrials.gov)
- P4 | N=161 | Completed | Sponsor: Validus Pharmaceuticals | Unknown status ➔ Completed
Trial completion • Bipolar Disorder • CNS Disorders • Mood Disorders • Psychiatry
March 03, 2023
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
(clinicaltrials.gov)
- P4 | N=17 | Terminated | Sponsor: Validus Pharmaceuticals | N=161 ➔ 17 | Completed ➔ Terminated; No apparent therapeutic effects that was superior to placebo
Enrollment change • Trial termination • Bipolar Disorder • CNS Disorders • Mood Disorders • Psychiatry
March 03, 2022
Nonopioid drugs for pain.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal • Immunology • Neuralgia • Osteoarthritis • Pain • Rheumatology
October 07, 2021
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
(clinicaltrials.gov)
- P=N/A; N=1037352; Completed; Sponsor: University of New Mexico; Enrolling by invitation ➔ Completed
HEOR • Trial completion • Bipolar Disorder • CNS Disorders • Mood Disorders • Psychiatry
1 to 9
Of
9
Go to page
1